GPCR
Structure
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
GPCR Profile
Structure Therapeutics Inc.
A biotech company developing oral small molecule therapies to treat various chronic diseases
Biological Technology
Invalid Date
02/03/2023
NASDAQ Stock Exchange
163
12-31
Depository Receipts (Ordinary Shares)
601 Gateway Blvd., Suite 900, South San Francisco, California 94080
--
Sudi Bio was established in the Cayman Islands in February 2019 and has operating subsidiaries in the United States and China. The company is a clinical-stage global biopharmaceutical company that develops and delivers novel oral therapies to treat a variety of chronic diseases to meet medical needs. The Company's differentiated technology platform leverages structure-based drug discovery and computational chemistry expertise, enabling the Company to develop oral small molecule therapies for the treatment of various diseases, including those affecting the metabolic, cardiovascular and pulmonary systems.